LinkMed’s (STO:LMED) portfolio company Likvor has received an order for
Likvor CELDA™ from Uppsala University Hospital (Akademiska
Universitetssjukhuset). With Likvor CELDA™ the clinical will be able to
dynamic measure the most important parameters concerning the patients’
cerebrospinal fluid including pressure and flow. Likvor CELDA™ was
developed to facility greater understanding and enhancing diagnosis of
normal pressure hydrocephalus (NPH), a condition that is often mistaken
for dementia. This is the second order for the instrument; the fist came
from Norrlands Universitetssjukhus, Umeå.
Likvor CELDA™ is the first commercially approved instrument for
assessing the flow of CSF fluid that surrounds the brain and spinal
cord. It increases the possibility for patients who suffer from NPH to
receive a correct diagnosis and therefore the appropriate treatment in
the form of a shunt implant that diverts and regulates CSF pressure and
flow. An accurate diagnosis means large gains for the patient and
family, but also for society as a whole.
Likvor CELDA™ is used with a special developed catheter, CELDA Tools™
that is a disposable for one time use only.
Hidden disease of old age Normal Pressure Hydrocephalus (NPH) is a
relatively unknown disease that is often mistakenly diagnosed as
dementia, Alzheimer’s or Parkinson’s. The is because the symptoms,
including disturbances in gait, confusion and urinary incontinence, are
similar to those of dementia, plus that NPH is a condition that mainly
occurs in people over the age of 55. Studies have shown that up to 10
percent of dementia patients may actually be suffering from NPH. In
Sweden it is estimated that over 7,000 Swedes suffer from the disease –
most of them unnecessarily. In the U.S., the corresponding figure is
well over 375,000. NPH is a condition that is relatively easily treated
by the insertion of a shunt, which helps the patient to regulate CSF
flow and pressure.